Fermer le menu


Member of Lyonbiopole


Founded in 2015 by two scientists, Géraldine Le Duc (CEO of NH TherAguix) and Pr Olivier Tillement (Professor of Chemistry at University of Lyon), NH TherAguix is a French biotechnology company based in Grenoble. NH TherAguix has developed an innovative theranostic nanodrug called AGuIX® that allows to fight more efficiently against all forms of cancer.

Thanks to a €13M fund raising in 2019 (BPI, Innobio, Omnes, Arbevel, Supernova), NH THerAguix was able to launch a promising portfolio of clinical trials.


Strategic application domain: Human Medicine

Application market: Oncology

Type of activity: Diagnostics, Therapeutics, Pharma or Biotech

Technologies: Drug delivery device & Technologies, Imaging, Nanotechnology

Created on dec. 15th, 2015 - 12 employees



29 chemin du vieux chêne 38240 Meylan



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.